These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 162677)

  • 21. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition of adverse drug reactions in depressed patients treated with viloxazine (Vicilan).
    Maistrello I; Grassi G; Bertolino A; Valerio P; Pistollato G; Soverini S
    Adv Biochem Psychopharmacol; 1982; 32():369-73. PubMed ID: 7090902
    [No Abstract]   [Full Text] [Related]  

  • 23. Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly.
    Moizeszowicz J; Subirá S
    J Clin Pharmacol; 1977 Jan; 17(1):81-3. PubMed ID: 319120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
    Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double-blind trial of 2 antidepressive drugs].
    De León O; Kravcio JT; Sánchez C
    Acta Psiquiatr Psicol Am Lat; 1977 Sep; 23(3):215-20. PubMed ID: 341650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentre study with viloxazine (Vivalan) in depressed patients.
    Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
    Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
    [No Abstract]   [Full Text] [Related]  

  • 27. Amitriptyline-perphenazine and doxepin in depressed outpatients: a controlled double-blind study.
    Rickels K; Csanalosi I; Werblowsky J; Weise CC; Weinstock R; Brown AS; Winokur A; Von Poelnitz M
    J Clin Psychiatry; 1982 Oct; 43(10):419-22. PubMed ID: 6749826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Convulsive seizures under viloxazine therapy].
    Langs T; Thomas F; Jupas JJ; Ravaud Y
    Presse Med; 1991 Mar; 20(10):477. PubMed ID: 1827182
    [No Abstract]   [Full Text] [Related]  

  • 29. A double blind comparison of viloxazine and amitryptyline in involutional and endogenous depression.
    Botter PA
    Acta Psychiatr Belg; 1979; 79(2):198-209. PubMed ID: 532690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does viloxazine really improve sex drive? A double-blind controlled study.
    De Leo D; Magni G
    Br J Psychiatry; 1986 May; 148():597-9. PubMed ID: 3535972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viloxazine hydrochloride in narcolepsy: a preliminary report.
    Guilleminault C; Mancuso J; Salva MA; Hayes B; Mitler M; Poirier G; Montplaisir J
    Sleep; 1986; 9(1 Pt 2):275-9. PubMed ID: 3704453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy profile of viloxazine. Open clinical trial with 34 patients].
    Pérez de Francisco C
    Neurol Neurocir Psiquiatr; 1976; 17(2):115-21. PubMed ID: 1052716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
    Lennox IG; Asbury JF; Couldrick WG; Beswick KB
    Practitioner; 1978 Jan; 220(1315):153-6. PubMed ID: 343090
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term tolerance of viloxazine].
    Brion S; Chevalier JF
    Encephale; 1982; 8(4):511-21. PubMed ID: 7151740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clorazepate: double blind crossover comparison of a single nightly dose with diazepam thrice daily in anxiety.
    Magnus RV; Dean BC; Curry SH
    Dis Nerv Syst; 1977 Oct; 38(10):819-21. PubMed ID: 20284
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Pinder RM; Brogden RN; Speight TM; Avery GS
    Drugs; 1977 Jun; 13(6):401-21. PubMed ID: 324751
    [No Abstract]   [Full Text] [Related]  

  • 38. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.
    Pisani F; Fazio A; Artesi C; Russo M; Trio R; Oteri G; Perucca E; Di Perri R
    J Neurol Neurosurg Psychiatry; 1992 Feb; 55(2):126-7. PubMed ID: 1538217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Viloxazine: its antidepressant action and lack of concomitant anticholinergic effect].
    Marchetti G; Amaducci L; Faravelli C; Matteini P; Pazzagli A
    Riv Patol Nerv Ment; 1977; 98(2):88-98. PubMed ID: 616014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of depressive conditions with viloxazine by the general practitioner].
    Haehn KD
    Fortschr Med; 1985 Apr; 103(15):408-12. PubMed ID: 3997018
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.